$$AcelRx制药(ACRX)$ FDA顾问小组主席严厉批评了 FDA 阿片类药物审批的做法,并呼吁停止考虑批准任何新的阿片类药物。据麻醉学家布朗( Brown )称,FDA倾向于将制药企业的利益置于公共健康之上, 查看全文...查看全文
Life-Struggle2018-12-18 23:37
$AcelRx制药(ACRX)$
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced it has been selected for additi...查看全文
Life-Struggle2018-12-12 13:29
$AcelRx制药(ACRX)$
Cantor Fitzgerald Reiterates a Buy Rating on Acelrx (ACRX)
Post ACRX’s analyst day in NYC, we reiterate our Overweight rating and 12-month price target of $9. Despite Dsuvia approval on the large market opportunity ahead for the pain product, we b...查看全文
Life-Struggle2018-12-03 12:12
$AcelRx制药(ACRX)$ An underappreciated growth story
George Budwell (AcelRx Pharmaceuticals): If you're looking for a promising under-the-radar growth stock to buy and hold for the long term, AcelRx Pharmaceuticals is a company definitely worth checking out right now. ...查看全文
Life-Struggle2018-11-30 10:43
$AcelRx制药(ACRX)$ AcelRx Pharmaceuticals to Host Analyst and Investor Day on December 11查看全文
$AcelRx制药(ACRX)$ 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001437749-24-000938 Act: 34 Size: 395 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058578 Size: 5 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058487 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058489 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058481 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058486 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058474 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058477 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058479 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003509 Act: 33 Size: 1 KB 网页链接